Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma.

Front Oncol · 2020 · PMC7198869 · PMID 32411594

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

( 24 ), in preliminary results of a phase III trial comparing PBT with TACE, showed a trend toward superior local tumor control and lower toxicity for PBT compared with TACE.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.